Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
AARD
AARD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AARD News
Aardvark Therapeutics Faces Investigation After Trial Pause
5d ago
Globenewswire
Aardvark Pauses Phase 3 Trial, Stock Plunges 61%
6d ago
Benzinga
Aardvark Therapeutics Faces Securities Fraud Investigation
6d ago
Globenewswire
Wall Street Analysts Adjust Ratings on Key Stocks
Mar 03 2026
Benzinga
U.S. Stocks Mixed Amid Iran-U.S. Conflict; Energy Shares Rise
Mar 02 2026
Benzinga
U.S. Stocks Open Lower; Energy Shares Rise Amid Mixed Economic Data
Mar 02 2026
Benzinga
Aardvark Pauses HERO Phase 3 Trial Amid Safety Concerns
Mar 02 2026
stocktwits
Wall Street Analysts Adjust Ratings on Key Stocks
Mar 02 2026
Benzinga
Wall Street Analysts Adjust Ratings
Mar 02 2026
Benzinga
Aardvark Pauses HERO Trial, Shares Plummet
Mar 02 2026
Benzinga
U.S. Stock Futures Plunge Amid Iran Conflict Escalation
Mar 02 2026
Benzinga
AMTD Digital Inc Reports 565.7% Revenue Growth in FY25
Mar 02 2026
Benzinga
Aardvark Therapeutics Faces Investigation After Trial Pause
Feb 28 2026
Businesswire
Aardvark Therapeutics Pauses HERO Trial Amid Safety Concerns
Feb 28 2026
NASDAQ.COM
Aardvark Pauses PWS Trial, Shares Plunge 53%
Feb 28 2026
stocktwits
AARDVARK THERAPEUTICS INC - TEMPORARY HALT CAUSED BY CARDIAC FINDINGS AT ELEVATED DOSES
Feb 27 2026
moomoo
Show More News
